ELOX Annual EBITDA
-$33.42 M
+$31.09 M+48.19%
31 December 2022
Summary:
As of January 21, 2025, ELOX annual earnings before interest, taxes, depreciation & amortization is -$33.42 million, with the most recent change of +$31.09 million (+48.19%) on December 31, 2022. During the last 3 years, it has risen by +$15.28 million (+31.37%).ELOX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELOX Quarterly EBITDA
-$3.17 M
+$757.00 K+19.28%
30 September 2023
Summary:
As of January 21, 2025, ELOX quarterly earnings before interest, taxes, depreciation & amortization is -$3.17 million, with the most recent change of +$757.00 thousand (+19.28%) on September 30, 2023. Over the past year, it has increased by +$3.66 million (+53.60%). ELOX quarterly EBITDA is now -273.23% below its all-time high of $1.83 million, reached on June 30, 2010.ELOX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELOX TTM EBITDA
-$18.21 M
+$3.66 M+16.74%
30 September 2023
Summary:
As of January 21, 2025, ELOX TTM earnings before interest, taxes, depreciation & amortization is -$18.21 million, with the most recent change of +$3.66 million (+16.74%) on September 30, 2023. Over the past year, it has increased by +$21.10 million (+53.67%). ELOX TTM EBITDA is now -4453.50% below its all-time high of -$400.00 thousand, reached on December 31, 1999.ELOX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELOX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.2% | +53.6% | +53.7% |
| 3 y3 years | +31.4% | +48.5% | +52.1% |
| 5 y5 years | -58.1% | +77.2% | +62.6% |
ELOX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.2% | at high | +72.3% | at high | +72.9% |
| 5 y | 5-year | -2.5% | +48.2% | at high | +91.0% | at high | +72.9% |
| alltime | all time | <-9999.0% | +48.2% | -273.2% | +91.0% | -4453.5% | +72.9% |
Eloxx Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$3.17 M(-19.3%) | -$18.21 M(-16.7%) |
| June 2023 | - | -$3.93 M(-29.4%) | -$21.88 M(-21.8%) |
| Mar 2023 | - | -$5.56 M(-0.0%) | -$27.98 M(-16.3%) |
| Dec 2022 | -$33.42 M(-48.2%) | -$5.56 M(-18.6%) | -$33.44 M(-14.9%) |
| Sept 2022 | - | -$6.83 M(-31.9%) | -$39.31 M(-6.1%) |
| June 2022 | - | -$10.03 M(-8.9%) | -$41.87 M(-37.7%) |
| Mar 2022 | - | -$11.02 M(-3.6%) | -$67.24 M(+4.2%) |
| Dec 2021 | -$64.51 M(+97.9%) | -$11.43 M(+21.9%) | -$64.51 M(+9.8%) |
| Sept 2021 | - | -$9.38 M(-73.5%) | -$58.74 M(+5.8%) |
| June 2021 | - | -$35.41 M(+327.3%) | -$55.50 M(+102.0%) |
| Mar 2021 | - | -$8.29 M(+46.3%) | -$27.47 M(-15.7%) |
| Dec 2020 | -$32.60 M(-33.1%) | -$5.66 M(-7.9%) | -$32.60 M(-14.2%) |
| Sept 2020 | - | -$6.15 M(-16.7%) | -$38.00 M(-13.9%) |
| June 2020 | - | -$7.38 M(-45.0%) | -$44.14 M(-12.8%) |
| Mar 2020 | - | -$13.41 M(+21.3%) | -$50.60 M(+3.8%) |
| Dec 2019 | -$48.70 M(+4.0%) | -$11.06 M(-10.0%) | -$48.73 M(-5.5%) |
| Sept 2019 | - | -$12.29 M(-11.1%) | -$51.55 M(+2.4%) |
| June 2019 | - | -$13.83 M(+19.8%) | -$50.32 M(+0.3%) |
| Mar 2019 | - | -$11.55 M(-16.8%) | -$50.17 M(+11.3%) |
| Dec 2018 | -$46.84 M(+121.7%) | -$13.88 M(+25.5%) | -$45.10 M(+44.5%) |
| Sept 2018 | - | -$11.06 M(-19.2%) | -$31.22 M(+46.6%) |
| June 2018 | - | -$13.69 M(+111.4%) | -$21.29 M(+69.6%) |
| Mar 2018 | - | -$6.47 M(+472.1%) | -$12.56 M(+81.7%) |
| Dec 2017 | -$21.13 M(+223.8%) | - | - |
| Sept 2017 | - | -$1.13 M(-77.2%) | -$6.91 M(-5.9%) |
| June 2017 | - | -$4.95 M(+1389.4%) | -$7.34 M(-11.6%) |
| June 2017 | -$6.53 M(-26.3%) | - | - |
| Mar 2017 | - | -$332.50 K(-32.6%) | -$8.31 M(-6.3%) |
| Dec 2016 | - | -$493.60 K(-68.4%) | -$8.86 M(-4.7%) |
| Sept 2016 | - | -$1.56 M(-73.6%) | -$9.30 M(+5.0%) |
| June 2016 | -$8.85 M(-50.5%) | -$5.92 M(+565.5%) | -$8.85 M(-37.7%) |
| Mar 2016 | - | -$889.10 K(-4.2%) | -$14.21 M(-2.0%) |
| Dec 2015 | - | -$928.50 K(-17.0%) | -$14.51 M(-10.2%) |
| Sept 2015 | - | -$1.12 M(-90.1%) | -$16.17 M(-9.6%) |
| June 2015 | -$17.88 M(+103.3%) | -$11.28 M(+850.7%) | -$17.88 M(+72.7%) |
| Mar 2015 | - | -$1.19 M(-54.1%) | -$10.36 M(-7.6%) |
| Dec 2014 | - | -$2.59 M(-8.8%) | -$11.21 M(+10.6%) |
| Sept 2014 | - | -$2.83 M(-24.4%) | -$10.14 M(+15.3%) |
| June 2014 | -$8.80 M(+54.1%) | -$3.75 M(+83.6%) | -$8.80 M(+19.4%) |
| Mar 2014 | - | -$2.04 M(+35.3%) | -$7.37 M(+17.0%) |
| Dec 2013 | - | -$1.51 M(+1.2%) | -$6.30 M(+4.6%) |
| Sept 2013 | - | -$1.49 M(-35.7%) | -$6.02 M(+5.4%) |
| June 2013 | -$5.71 M(+18.2%) | -$2.32 M(+138.6%) | -$5.71 M(+25.2%) |
| Mar 2013 | - | -$972.80 K(-21.1%) | -$4.56 M(-1.5%) |
| Dec 2012 | - | -$1.23 M(+4.3%) | -$4.63 M(-3.4%) |
| Sept 2012 | - | -$1.18 M(+0.8%) | -$4.79 M(+5.1%) |
| June 2012 | -$4.83 M(-18.7%) | -$1.17 M(+12.5%) | -$4.56 M(-7.7%) |
| Mar 2012 | - | -$1.04 M(-25.3%) | -$4.94 M(-5.8%) |
| Dec 2011 | - | -$1.39 M(+46.6%) | -$5.25 M(+6.5%) |
| Sept 2011 | - | -$951.10 K(-38.7%) | -$4.93 M(-17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | -$5.94 M(+25.9%) | -$1.55 M(+15.2%) | -$5.94 M(+132.3%) |
| Mar 2011 | - | -$1.35 M(+25.4%) | -$2.56 M(-59.5%) |
| Dec 2010 | - | -$1.07 M(-45.2%) | -$6.31 M(-6.2%) |
| Sept 2010 | - | -$1.96 M(-207.3%) | -$6.72 M(+17.6%) |
| June 2010 | -$4.72 M(+13.1%) | $1.83 M(-135.9%) | -$5.71 M(-34.6%) |
| Mar 2010 | - | -$5.10 M(+242.5%) | -$8.74 M(+89.6%) |
| Dec 2009 | - | -$1.49 M(+55.7%) | -$4.61 M(+6.7%) |
| Sept 2009 | - | -$955.90 K(-19.9%) | -$4.32 M(+3.5%) |
| June 2009 | -$4.17 M(+19.2%) | -$1.19 M(+23.0%) | -$4.17 M(+5.3%) |
| Mar 2009 | - | -$970.40 K(-19.2%) | -$3.96 M(+9.7%) |
| Dec 2008 | - | -$1.20 M(+48.6%) | -$3.61 M(+17.4%) |
| Sept 2008 | - | -$808.00 K(-17.9%) | -$3.08 M(+18.2%) |
| June 2008 | -$3.50 M(+11.0%) | -$984.50 K(+58.7%) | -$2.60 M(+13.4%) |
| Mar 2008 | - | -$620.20 K(-6.9%) | -$2.30 M(-4.2%) |
| Dec 2007 | - | -$666.40 K(+99.7%) | -$2.40 M(-16.9%) |
| Sept 2007 | - | -$333.70 K(-50.7%) | -$2.88 M(-8.6%) |
| June 2007 | -$3.15 M(-6.6%) | -$676.60 K(-6.1%) | -$3.15 M(-3.6%) |
| Mar 2007 | - | -$720.70 K(-37.5%) | -$3.27 M(-0.3%) |
| Dec 2006 | - | -$1.15 M(+90.8%) | -$3.29 M(+7.2%) |
| Sept 2006 | - | -$604.30 K(-24.1%) | -$3.06 M(-9.3%) |
| June 2006 | -$3.38 M(+3.1%) | -$796.00 K(+8.8%) | -$3.38 M(-1.5%) |
| Mar 2006 | - | -$731.80 K(-21.5%) | -$3.43 M(-4.9%) |
| Dec 2005 | - | -$931.70 K(+1.3%) | -$3.61 M(+3.8%) |
| Sept 2005 | - | -$919.70 K(+8.5%) | -$3.48 M(+6.0%) |
| June 2005 | -$3.28 M(-18.2%) | -$848.00 K(-6.8%) | -$3.28 M(-14.7%) |
| Mar 2005 | - | -$910.20 K(+14.0%) | -$3.84 M(+8.7%) |
| Dec 2004 | - | -$798.30 K(+10.6%) | -$3.54 M(-2.6%) |
| Sept 2004 | - | -$721.50 K(-49.0%) | -$3.63 M(-15.8%) |
| June 2004 | -$4.01 M(+79.7%) | -$1.41 M(+134.5%) | -$4.31 M(+27.7%) |
| Mar 2004 | - | -$603.00 K(-32.3%) | -$3.38 M(+2.7%) |
| Dec 2003 | - | -$890.90 K(-36.5%) | -$3.29 M(+6.0%) |
| Sept 2003 | - | -$1.40 M(+193.3%) | -$3.10 M(+39.1%) |
| June 2003 | -$2.23 M(+6.7%) | -$478.70 K(-6.9%) | -$2.23 M(+5.5%) |
| Mar 2003 | - | -$514.20 K(-27.1%) | -$2.11 M(+1.2%) |
| Dec 2002 | - | -$705.30 K(+32.6%) | -$2.09 M(-1.9%) |
| Sept 2002 | - | -$531.80 K(+46.8%) | -$2.13 M(+1.9%) |
| June 2002 | -$2.09 M(+7.3%) | -$362.30 K(-26.0%) | -$2.09 M(-2.2%) |
| Mar 2002 | - | -$489.80 K(-34.3%) | -$2.14 M(+2.0%) |
| Dec 2001 | - | -$745.40 K(+51.4%) | -$2.09 M(+9.0%) |
| Sept 2001 | - | -$492.40 K(+20.3%) | -$1.92 M(-1.3%) |
| June 2001 | -$1.95 M(-19.8%) | -$409.30 K(-8.4%) | -$1.95 M(-9.8%) |
| Mar 2001 | - | -$446.90 K(-22.0%) | -$2.16 M(-15.0%) |
| Dec 2000 | - | -$572.70 K(+10.5%) | -$2.54 M(+7.3%) |
| Sept 2000 | - | -$518.10 K(-16.4%) | -$2.37 M(+28.0%) |
| June 2000 | -$2.43 M(+110.8%) | -$620.00 K(-25.1%) | -$1.85 M(+50.5%) |
| Mar 2000 | - | -$827.40 K(+106.8%) | -$1.23 M(+206.8%) |
| Dec 1999 | - | -$400.00 K | -$400.00 K |
| June 1999 | -$1.15 M(<-9900.0%) | - | - |
| June 1998 | $0.00(0.0%) | - | - |
| June 1997 | $0.00 | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual EBITDA year-on-year change?
- What is Eloxx Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Eloxx Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM EBITDA year-on-year change?
What is Eloxx Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ELOX is -$33.42 M
What is the all time high annual EBITDA for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is $0.00
What is Eloxx Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ELOX annual earnings before interest, taxes, depreciation & amortization has changed by +$31.09 M (+48.19%)
What is Eloxx Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ELOX is -$3.17 M
What is the all time high quarterly EBITDA for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $1.83 M
What is Eloxx Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ELOX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$3.66 M (+53.60%)
What is Eloxx Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ELOX is -$18.21 M
What is the all time high TTM EBITDA for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$400.00 K
What is Eloxx Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ELOX TTM earnings before interest, taxes, depreciation & amortization has changed by +$21.10 M (+53.67%)